Despite skiing's complicated phrases, slang, and descriptors when it comes to snow and gear, the sport uses a rather simple ...
Black Diamond Therapeutics' partnership with Servier presents a major buying opportunity. BDTX is trading below its net cash ...
Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today announced ...
Experts say that while data ownership might at first be time-consuming and costly, the long-term benefits make it an ...
Servier announces a strategic worldwide licensing agreement for Black Diamond Therapeutics' BDTX-4933 for solid tumors for an ...
10d
Courier-Herald on MSNBlack Diamond again studies fire, emergency services optionsThe city of Black Diamond has begun a fire protection and emergency services feasibility study in the midst of potentially ...
Murphy-Pitard Jewelers is collaborating with the South Arkansas Arts Center for a special raffle featuring the 'Imperfectly ...
11d
GlobalData on MSNServier and Black Diamond sign deal for solid tumours therapyServier and Black Diamond Therapeutics have signed a licensing agreement for a targeted therapy, BDTX-4933, to treat solid ...
1d
Powder on MSNThe 7 Best Ways To Cross-Train for SkiingEven though we all wish we could just ski, here are a few ways to cross-train for skiing and stay strong in the off-season.
Wedbush reissued their outperform rating on shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) in a research ...
Servier and Black Diamond Therapeutics (BDTX) announced a strategic worldwide licensing agreement for BDTX-4933, a potential best-in-class ...
Black Diamond Therapeutics has found a partner for its deprioritized solid tumor candidate. Five months after cutting support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results